Yaz – FDA Orders Bayer to Correct Deceptive Yaz Advertising

In October 2008, the makers of Yaz were ordered by product-safety authorities to correct two 60-second television ads for their product. Officials concluded the TV spots contained inaccurate and misleading statements that overstated the efficacy of the drug. The advertisements which were designed to correct earlier misleading ads featured a group of women discussing the relative benefits and risks of taking Yaz while lounging in a hip nightclub setting and reportedly cost the company $20 million to produce and distribute.

If you have a similar problem and would like to be contacted by our lawyers at no cost or obligation, please click the link below.  Contact Our Personal Injury Law Firm.